Careaga-Reyna G, Ramírez-Castañeda A, Sánchez-Ramírez O, Jiménez-Valdivia M, Arellano-Villavicencio Á, Argüero-Sánchez R

Language: Spanish
References: 12
Page: 291-294
PDF size: 42.06 Kb.

ABSTRACT

Introduction: To evaluate the efficacy of a cell recovery system to avoid use of homologous blood. Material and method: We analyzed 26 patients (11 female and 15 male) with mean age of 55 years and a range of 28 to 75 years, programmed to elective surgery, without hepatic failure or exposure to oral anticoagulants or aspirin within 7 days before surgery. They were randomized in two groups: Group I with the cell recovery system, and group II as control. We evaluated hematocrit value, intraoperative and postoperative bleeding, and the homologous red blood cells units employed. Results: There were no differences between hematocrit values or perioperative bleeding. However, in group I 94.8% of homologous red blood cells unit was not used compared with group II (78.2%) in the operating room; in the postoperative care unit in group I, 56.4% of the homologous units was not used. In group II, only 15.3% of the units was not employed. Total volume obtained to transfusion after centrifugation in the cell recovery system was 756 ± 436 cc. Discussion: It was concluded that with the cell recovery system, use of homologous blood cell units may be decreased in open heart surgery.

REFERENCES

1. Harker LA. Bleeding after cardiopulmonary bypass. N Engl J Med 1986;314:1446-48.

2. Ferraris VA, Ferraris SP, Lough FC, Betty W. Preoperative aspirin ingestion increases operative blood loss after coronary artery bypass grafting. Ann Thorac Surg 1988;45:71-74.

3. Souto-Merino CA, Simón J, Pulido MA, Hernández A, García IC, del Río CA. The prevalence of markers for hepatitis A, B and C in a hospital in Mexico. Salud Pública Mex 1994;36:257-62.

4. Santoli E. Safety of preoperative blood donation (for autotransfusion) for cardiac surgery patients. Transfusion 1993;33:91-5

5. Cordell AR, Lavender S. An appraisal of blood salvage techniques in vascular and cardiac operations. Ann Thorac Surg 1980;31:421-25.

6. Argüero R, Careaga G. Hemodilución. Fundamentos y aplicaciones en cirugía. Rev Med IMSS (Mex) 1995;33:91-6.

7. Scott WJ, Rode R, Castleman B, Kessler R, Follis F, Pett SB, et al. Efficacy, complications and cost of a comprehensive blood conservation program for cardiac operations. J Thorac Cardiovasc Surg 1992; 5:1001-7.

8. Laub G, Dharan M, Riebman J, Chen C, Moore R, Bailey B, et al. The impact of intraoperative autotransfusion on cardiac surgery. A prospective randomized double-blind study. Chest 1993;104: 686-89.

9. Ansell J, Parrilla N, King M, Fournier L, Szymanski I, Doherty P, et al. Survival of autotransfused red blood cells recovered from the surgical field during cardiovascular operations. J Thorac Cardiovasc Surg 1982;84:387-91.

10. Holmes JH IV, Jones MF, Anderson RP, Knopes KD, Guyton SW, Hall RA. The use of micro-dose aprotinin continuous infusion in coronary artery bypass surgery. J Cardiovasc Surg 1999;40:621-6.

11. Wolpert E, Córdova MS. El papel de la Secretaría de Salud en la prevención de las enfermedades por transfusión de sangre. Gac Med Mex 1994;130:412-14.

12. Jeanne VL, Harold S. Transfusion errors: causes and effects. Transfusion Med Rev 1994;8:169-83.